Former Optum exec Mike Ott and health start-up pioneer Kurt Cegielski to drive growth in payer, employer markets for unique MOBE offerings MINNEAPOLIS–(BUSINESS WIRE)–MOBE, a health outcomes company focused on improving peoples’ health while reducing healthcare costs, today announced the appointments of Mike Ott as Chief Executive Officer and Kurt Cegielski as Chief Commercial Officer—Health … [Read more…]
MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–BetterHelp, the world’s largest therapy platform, has announced the Future of Mental Health Scholarship, a fund that will award 10 college students with academic scholarships of $10,000 to be used toward the 2022-2023 school year. With a mission of making high-quality mental health care accessible and affordable for anyone in need, BetterHelp … [Read more…]
The study demonstrates the importance of tumor and lymph node-derived B cells for the discovery of antibodies directed at potentially novel targets The study results provide a framework for understanding the evolution of B cell families in cancer patients EXTON, Pa.–(BUSINESS WIRE)–Immunome, Inc. (Nasdaq: IMNM), a biopharmaceutical company that utilizes its human memory B cell … [Read more…]
As Empire works to materially and measurably improve the health of all New Yorkers, these new partnerships support more than 5,500 behavioral healthcare providers to be active in the Empire network, making behavioral healthcare more accessible for members NEW YORK–(BUSINESS WIRE)–Today, Empire BlueCross BlueShield (Empire) is announcing a suite of innovative companies that are joining … [Read more…]
Resilience will aid in the development of CIRM grant applications as a biomanufacturing partner with awardees who are developing novel regenerative medicines and cell therapies. SAN DIEGO–(BUSINESS WIRE)–#biomanufacturing—National Resilience, Inc. (Resilience), a technology-focused biomanufacturing company dedicated to broadening access to complex medicines, was named by the California Institute for Regenerative Medicine (CIRM) as one of … [Read more…]
A novel RNA-based IL-2 treatment response classifier was developed as part of the study in patients with renal cell carcinoma DURHAM, N.C.–(BUSINESS WIRE)–#GeneCentric—GeneCentric Therapeutics, a company making precision medicine more precise through RNA-based diagnostics, announced its new publication in Cancer Research Communications that compares the immunogenomic response profiles to anti-PD-(L)1 or IL-2 therapy and the … [Read more…]
WALTHAM, Mass.–(BUSINESS WIRE)–Mythic Therapeutics, a biotechnology company focused on the development of antibody-drug conjugate-based therapies for the treatment of a wide range of cancers, announced today the appointment of Gilles Gallant, BPharm, PhD, FOPQ, to the new position of Chief Development Officer. The company also announced that Mythic co-founder and CEO Alex Nichols, PhD, has … [Read more…]
Submission seeks marketing authorization for first-line use in combination with chemotherapy in advanced esophageal squamous cell carcinoma CAMBRIDGE, Mass. & BASEL, Switzerland & BEIJING–(BUSINESS WIRE)–BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company focused on developing and commercializing innovative and affordable oncology medicines to improve treatment outcomes and access for patients worldwide, today … [Read more…]
AMSTERDAM–(BUSINESS WIRE)–VectorY, a biotech company focusing on the development of innovative gene therapy approaches for the treatment of neurodegenerative and muscular disorders through vectorized antibodies, announces today that it will present a poster at the Hereditary Disease Foundation 2022 Meeting in Cambridge, Massachusetts, on August 24-27, 2022. The poster shows that VectorY’s AAV vector, dose-dependently … [Read more…]
Namodenoson induced a complete response with disappearance of all metastases in a patient who will now continue the treatment under a compassionate use program in Romania Can Fite’s Phase III pivotal study is open for patient enrolment PETACH TIKVA, Israel–(BUSINESS WIRE)–Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary … [Read more…]
